US Marshals Seize Pharmaceutical Innovations' Contaminated Ultrasound Gel That Allegedly Sickened 16 Patients

Published: Apr 20, 2012

The US Food and Drug Administration (FDA) has announced that acting upon its request, US Marshals have seized Other-Sonic Generic Ultrasound Transmission gel located at Pharmaceutical Innovations Inc. in Newark, New Jersey, after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product1 manufactured between June 2011 and December 2011.

Back to news